Abstract
Dam identification (DamID) is a powerful technique to generate genome-wide maps of chromatin protein binding. Due to its high sensitivity, it is particularly suited to study the genome interactions of chromatin proteins in small tissue samples in model organisms such as Drosophila. Here, we report an intein-based approach to tune the expression level of Dam and Dam-fusion proteins in Drosophila by addition of a ligand to fly food. This helps to suppress possible toxic effects of Dam. In addition, we describe a strategy for genetically controlled expression of Dam in a specific cell type in complex tissues. We demonstrate the utility of the latter by generating a glia-specific map of Polycomb in small samples of brain tissue. These new DamID tools will be valuable for the mapping of binding patterns of chromatin proteins in Drosophila tissues and especially in cell lineages.
INTRODUCTION
Structural and regulatory components of chromatin are responsible for control of gene expression, DNA replication, and genome maintenance. Genome-wide mapping of chromatin proteins contributes to the understanding of the mechanisms of these processes. One of the techniques for this purpose is Dam identification (DamID) (1,2), which is based on in vivo expression of a chromatin protein of interest fused to DNA adenine methyltransferase (Dam). This way, Dam is targeted to the native binding sites of its fusion partner and methylates adenines in GATC sequences in their immediate vicinity. The methylated regions are subsequently selectively amplified from genomic DNA and identified by microarray hybridization or high-throughput sequencing. DamID has been successfully applied in a broad range of species (3–9). Particularly in Drosophila the method has been used to study a large diversity of DNA-binding factors and chromatin proteins (10,11).
In general, a requirement for DamID experiments is that the expression level of the Dam fusion proteins is kept very low in order to avoid saturating methylation of genomic DNA due to the high enzymatic activity of Dam, and to prevent mis-targeting of the Dam fusion protein (2,12). In Drosophila cultured cells, larvae and flies, this low expression is typically achieved by means of the low leaky activity of the hsp70 heat-shock promoter in the absence of heat shock.
However, it is often desirable that the expression of the Dam fusion protein is controllable. For example, one may need to express a Dam fusion protein in a defined time window, for example to study a specific developmental stage or after application of a certain stimulus. In addition, it is useful to be able to activate Dam expression only in a particular cell type of interest. Because the amplification of Dam-methylated DNA is highly specific (13,14) and extremely sensitive (15), such selective expression would make it possible to generate cell type specific protein binding maps from small heterogeneous tissue samples without the need to purify the cells of interest. A requirement for this strategy is that the Dam activity is strictly limited to the cell type of interest, otherwise signals will be picked up from irrelevant cell types.
Another reason why controllable expression of Dam fusion proteins is desirable lies in possible toxic effects. Although it was originally reported that expression of Dam in Drosophila has no detectable effects on fly development and viability (16), subsequent experiments indicated that transgenesis with Dam-expressing vectors can be inefficient (14,17). For example, in an attempt to generate Dam-only, SUUR-Dam and Dam-SUUR transgenic flies by random integration we found that the transgenes were inactivated in 14 out of 14 independent lines due to sequence rearrangements (A.V.P., unpublished data), suggesting strong negative selection. Furthermore, we observed very low efficiency of phiC31 integrase-mediated site-specific insertion of Dam-histone H1 and Dam-BRM transgenes: 0 and 1 line from 200 and 400 embryos injected, respectively (J. van Bemmel and B.v.S., unpublished data). The underlying cause of the inefficient transgenesis of Dam constructs has never been satisfactorily explained. However, the suspected toxicity problem may be overcome by reducing the activity of the Dam fusion protein, or by restricting its expression to the cells or tissue of interest.
Here, we report two approaches to achieve controllable activity of Dam fusion proteins. First, we designed a ligand-dependent version of Dam that enables the tuning of Dam activity in Drosophila tissues. In addition, we present a genetically controllable binary switch to express Dam fusion proteins selectively in a Drosophila cell type or tissue of choice, and we demonstrate its utility for generating cell type specific binding maps of the Polycomb protein. We discuss the merits of these and other recently reported systems for controllable Dam expression in Drosophila.
MATERIALS AND METHODS
Dam-containing plasmid constructs
Plasmid constructs are described in the Extended Experimental Procedures.
Fly stocks and handling
Transgenic flies were generated using phiC31 integrase-mediated site-specific transgenesis system (18) by the BestGene company (http://www.thebestgene.com/). All Dam-containing plasmid constructs were injected into embryos containing attP site at cytogenetic location 51C (y[1] M{vas-int.Dm}ZH-2A w[*]; M{3xP3-RFP.attP’}ZH-51C; Bloomington stock no. 24482). Up to five independent transformant lines were established for each construct and only homozygous-viable lines were chosen for the experiments. All transgenic lines were verified by genotyping PCR (data not shown).
The Oregon-R strain was used as wild type. The repo-FLP stock (19) was provided by Christian Klämbt (Institut für Neurobiologie, Universität Münster, Münster, Germany). The βTub85D-FLP stock was obtained from the Bloomington Drosophila Stock Center (no. 7196). The y[*] w[*] strain was provided by François Karch (University of Geneva, Geneva, Switzerland). Flies were raised at 25°C on standard cornmeal/molasses/agar medium. To induce 4-HT-intein splicing, fly food was supplemented with 4-hydroxytamoxifen (Sigma-Aldrich, H7904) at a final concentration of 25 μM. Mated female flies were then allowed to lay eggs on this food, so the resulting larvae were exposed to 4-HT from hatching until they were collected in the third instar stage.
RNA-seq
For each gene expression sample, larval central brain or fat bodies were dissected into TRIzol reagent (Invitrogen, 15596-018). Tissues were dissected from male wandering third instar larvae. For each tissue/condition, two independent samples were processed. RNA-seq was performed using an Illumina HiSeq 2000 instrument and standard Illumina protocol. Differentially expressed genes were identified by using the R package DESeq (20,21; http://www-huber.embl.de/users/anders/DESeq/).
DamID-seq
Isolation of total DNA from whole adults, larval central brain and fat bodies is described in the Extended Experimental Procedures. For each stage/tissue/protein/condition, two independent samples were processed. For the larval central brain and fat body samples, the appropriate tissues were dissected from male wandering third instar larvae. For the repo-positive glial cell samples, no gender selection was employed; a mix of male and female wandering third instar larvae was used for dissection of larval central brains. Methylated GATC DNA sequences were amplified by DpnI digestion followed by ligation-mediated PCR as described previously (22) with a minor modification: 500 ng instead of 2.5 μg of DNA was used as an input. For the experiments with an individual Drosophila larval central brain, total amount of isolated DNA was used as an input. The amplified methylated DNA fragments were purified using QIAquick PCR Purification kit (QIAGEN, 28104) according to the manufacturer's instructions, eluted in nuclease-free water (Ambion, AM9938) and quantified on a NanoDrop spectrophotometer. Preparation of the purified DNA for Illumina sequencing is described in the Extended Experimental Procedures. 50 bp single-end read cycles of sequencing were performed on an Illumina HiSeq 2000 machine.
Processing of DamID-seq fastq files
Because reads with GATC sites contain the DamID adapter sequence, this sequence was first clipped from such reads using the software package ‘cutadapt’ (version 1.2.1; https://cutadapt.readthedocs.org/en/stable/). All reads were then aligned to the Drosophila melanogaster genome (release 5) using the short read alignment software ‘bowtie2’ (version 2.0.0-beta2; http://bowtie-bio.sourceforge.net/bowtie2/index.shtml). Next, the reads were mapped onto GATC fragments using the software ‘HTSeq-count’ (version 0.5.3p3; http://www-huber.embl.de/users/anders/HTSeq/doc/index.html). Next, counts were normalized to the total number of reads. Finally, Dam4-HT-intein@L127C-PC and STOP#1-Dam-PC data were normalized to the Dam4-HT-intein@L127C and STOP#1-Dam alone controls, respectively, and the replicates were averaged. A detailed description of data transformation and the code are available upon request.
Data release
DamID-seq and RNA-seq data are available from the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/), accession number GSE75835.
RESULTS
Construction of a ligand-controlled Dam vector for use in Drosophila tissues
In order to establish a ligand-inducible version of Dam we tested an intein-based molecular switch (Figure 1A). Inteins are internal protein elements catalyzing their own excision and joining of the flanking polypeptide sequences. Modified inteins can promote conditional protein splicing in a ligand-dependent manner (23,24). We reasoned that insertion of such a modified intein within Dam might block its enzymatic activity, which can be restored by the activation of intein splicing. Based on the crystal structure of Dam we chose eight different positions (S57, C87, L127, R128, C162, A170, C180 and H220) for the insertion of the 4-hydroxytamoxifen-inducible intein (23) (hereafter, 4-HT-intein). Because intein splicing requires the presence of a cysteine residue in the host protein immediately downstream of the inserted intein (23–25), we first tested whether S57C, L127C, R128C, A170C and H220C mutations affect the functioning of the Dam enzyme. We introduced these mutations in the pNDamMyc plasmid encoding Dam under the control of the Drosophila heat-shock promoter hsp70 (1).
To assay the activity of the Dam mutants, we took advantage of a fortuitous observation that the hsp70 promoter can drive Dam expression in E. coli. We amplified the mutant-encoding plasmids in a dam- E. coli strain and then isolated and digested the plasmids with DpnI and DpnII restriction enzymes that cut only Gm6ATC and unmethylated GATC motifs, respectively. This revealed that all tested Dam mutants retained DNA adenine methyltransferase activity (Figure 1B).
Next, we cloned the 4-HT-intein in the pNDamMyc plasmid at the selected (and, where necessary, mutated) positions in Dam. We did not detect any adenine methylation in dam- bacteria transformed by the constructed plasmids and grown in the absence of 4-hydroxytamoxifen (4-HT). However, in the presence of the ligand (10 μM 4-HT), we observed partial methylation of some plasmid constructs (Figure 1C). We chose one of these promising chimeric constructs, with the 4-HT-intein inserted just before L127C (hereafter, Dam4-HT-intein@L127C), for the subsequent experiments in Drosophila flies.
For expression of Dam4-HT-intein@L127C proteins in Drosophila we decided to rely on the basal activity of the full-length hsp70 promoter. We inserted all Dam transgenes in the same genomic location (51C) by phiC31 integrase-mediated site-directed transgenesis (18). With this experimental setup, stable germline transformation of Drosophila with the Dam4-HT-intein@L127C-containing transgenes occurred with normal frequencies (Figure 2A). However, we detected Dam methylation in the transgenic animals grown in the absence of 4-HT, meaning that Dam4-HT-intein@L127C is only partially inactivated by the intein (Figure 2B). In some tissues in the absence of 4-HT we also observed a clear banded pattern in the amplified methylated DNA (Figure 2B). Sequencing of this DNA revealed that these discrete bands represent mitochrondrial DNA. This suggests that the Dam4-HT-intein@L127C is partially targeted to mitochondria, for which we do not have an explanation. Because mitochondrial DNA sequences are easily discerned from nuclear DNA sequences in DamID-seq, this does not substantially compromise the mapping. Induction of 4-HT-intein splicing by growing animals on fly food supplemented with 4-HT increases the activity of Dam and, as a result, the methylation of nuclear DNA, which in its turn reduces the proportion of mitochondrial DNA sequences in DamID samples (Figure 2B). Notably, mRNA sequencing of fat body tissues (two replicate experiments) suggested that the effects of 4-HT on gene expression are mild (Figure 2C and D).
To test whether Dam4-HT-intein@L127C can be used to generate a genome-wide DamID profile, we generated DamID-seq maps for Dam4-HT-intein@L127C-Polycomb (Dam4-HT-intein@L127C-PC) as well as unfused Dam4-HT-intein@L127C from dissected larval central brain and fat body tissue. These maps show the typical domain-like pattern of PC binding, similar to what we have previously observed in Kc cells (Figure 3A). Remarkably, the Dam4-HT-intein@L127C-PC DamID profile in larval central brain reproduced very well the profile generated previously by the original DamID approach (26) (Figure 3B, C) verifying the usability of the Dam4-HT-intein@L127C system. Thus, we constructed a ligand-inducible system for DamID profiling that appears to overcome toxicity problems, enables the tuning of Dam activity in Drosophila tissues, and can be used to generate DamID profiles from dissected tissues.
FLP-inducible Dam vectors for tissue-specific DamID profiling in Drosophila
Next, we constructed a system for cell type specific expression of Dam proteins. We placed a cassette consisting of a transcription terminator flanked by two directly repeated DNA recombinase recognition sites, between the promoter and the Dam protein coding region. This should prevent expression of Dam unless the cassette is excised by expression of the recombinase (Figure 4A). Thus, cell type-specific expression of the recombinase enables the generation of the corresponding DamID profiles using whole tissue as input.
We chose the FLP/FRT recombination system, which has been extensively used in Drosophila (27,28). Since even trace amounts of Dam can lead to substantial background methylation of the genome, the terminator should prevent transcription of the transgene coding region extremely effectively. The sequences previously successfully used as terminators in Drosophila transgenic constructs were mostly used in combination with genes encoding proteins without enzymatic activities (for example, GFP). Therefore, we first tested five candidate cassettes named STOP#1 through #5 (Table 1) for their ability to effectively prevent transcription of the Dam-containing transgene. We inserted each of the five cassettes, flanked by FRT sites, between the hsp70 promoter and an open reading frame encoding either Dam alone or a fusion protein of Dam and Lamin Dm0 (Dam-LAM). We chose LAM as Dam fusion partner because it is particularly suited to study genome—nuclear lamina interactions (29,30), which can undergo profound changes during differentiation (31).
Table 1. Tested terminator cassettes.
Terminator cassette | Length (bp) | Elements | Reference |
---|---|---|---|
STOP#1 | 1317 | C-terminal sequence of yeast His3 gene, the SV40 polyadenylation signal region, a false translation initiation signal and a 5′ splice donor site | (47) |
STOP#2 | 10 361 | inverted sequence of the yellow (y+) gene placed in the middle of the hsp70 3′UTR | (45) |
STOP#3 | 2436 | 3′UTR of the hsp70 gene alone | (45) |
STOP#4 | 1522 | SV40 and αTub84B polyadenylation signal regions | (48) |
STOP#5 | 3425 | HcRed gene and the Glutamine synthetase 1 (gs1) 3′UTR | (49) |
Already at the step of Drosophila transgenesis we observed significant differences between the terminator cassettes (Figure 4B). Efficient transgenesis was obtained only for STOP#1- and STOP#4-containing Dam-LAM constructs, indicating that other terminators might allow transcriptional read-through to some extent, causing toxicity. Indeed, the single fly line that we obtained with the STOP#3-Dam transgene showed high background levels of adenine methylation in the genomic DNA (data not shown), whereas not a single fly line was established with the STOP#3-Dam-LAM transgene.
To directly test whether a STOP cassette can prevent toxicity we devised a viability assay with one of the STOP#2-Dam-LAM lines (Figure 5). Although the FLP-out efficiency in the male germline was about two-fold lower than reported earlier (32), the genotype frequencies obtained were only compatible with a Dam toxicity scenario and prevention of this toxicity by the STOP#2 cassette. The relatively low level of transgenesis by the STOP#2-containing construct (Figure 4B) may have been caused by its relatively big size.
Next, we measured the background levels of DNA adenine methylation in adult transgenic flies. In animals with the STOP#1 and STOP#2 transgenes, leakage of Dam-LAM expression was minimal, since the amounts of amplified methylated fragments were only slightly higher compared to wild-type Oregon flies used as a negative control (Figure 4C and D). We detected substantially higher DNA methylation levels in the STOP#4 and STOP#5 animals. Because all the transgenes were inserted in the same genomic location (51C) to avoid position effect, we conclude that the STOP#1 and STOP#2 sequences are the best transcriptional terminators in Drosophila. We chose the STOP#1 sequence for subsequent experiments because of its smaller size and high transgenesis efficiency.
Comparison of the STOP#1-Dam-LAM transgenes driven by the full-length and the minimal hsp70 promoters revealed a negligible difference (Figure 4B and D). The minimal promoter does not respond to heat shock and therefore can be used in the combination with the hsp70-FLP transgene (33,34) to ubiquitously express Dam proteins at the low levels as an alternative to the inducible system based on the Dam4-HT-intein@L127C. Therefore, we finally selected the minimal hsp70 promoter along with the STOP#1 sequence for FLP-inducible expression of Dam proteins in Drosophila.
Proof-of-principle of cell type specific DamID profiling using STOP#1-Dam system
To test the utility of STOP#1-Dam system, we applied it to study the genome-wide binding profile of the Polycomb (PC) protein in glial cells, which constitute no more than 10% of all Drosophila larval brain cells (35). No Dam-dependent DNA methylation was detected in central brains dissected from STOP#1-Dam larvae, confirming that the STOP#1 sequence effectively terminates transcription initiated at the hsp70 promoter. To activate expression of STOP#1-Dam constructs, we used the repo-FLP transgene that provides FLP activity exclusively in glial cells, but not in other cell types (19). Indeed, a substantial level of DNA methylation at GATC sites was observed in central brains of repo-FLP/STOP#1-Dam trans-heterozygous larvae (Figure 6A and B). Comparison of the PC DamID profile for repo+ glial cells with that in whole larval central brain revealed many tissue-specific differences in addition to the overall similarity (Figure 6C). For example, we observed that the gcm gene—a glial lineage determination factor that is only expressed in glial cells and not in neurons (36)—is bound by PC in whole larval central brain, but not in repo+ glial cells (Figure 6D).
For this experiment and other ones described above, we combined tissue material from about 20 larvae. With the aim to identify the minimum amount of input material required for the STOP#1-Dam system, we checked whether a tissue dissected from a single larva is enough to detect Dam-specific methylation occurring only in a small proportion of its cells. Analysis of several individual repo-FLP/STOP#1-Dam and repo-FLP/STOP#1-Dam-LAM trans-heterozygous larval central brains showed that methylated GATC fragments can be specifically amplified in each case (Figure 6E). This high sensitivity suggests that the STOP#1-Dam-containing transgene may be used to generate DamID profiles in small subsets of cells within a complex tissue.
DISCUSSION
Here, we report two different systems to control the expression or activity of Dam-fusion proteins for DamID experiments in Drosophila. The Dam4-HT-intein@L127C system may be used to fine-tune Dam activity by addition of 4-HT to fly food. It appears relatively leaky in the absence of 4-HT, which may be due to spontaneous excision of the intein. Improvements in inducible intein technology (37) may reduce this background further. Nevertheless, Dam4-HT-intein@L127C construct is useful because it substantially reduces toxicity problems and it allows for tuning of the Dam activity when needed.
We find that the STOP#1-Dam system is much more tightly controllable than the intein-based system; in our experiments, STOP#1-Dam exhibited essentially no genome methylation in the absence of FLP recombinase. This low leakiness combined with the extreme sensitivity and specificity of the protocol for amplification of Dam-methylated DNA (14,15; this study) creates opportunities to map chromatin protein binding in specific cell types in complex tissues. For this purpose many GAL4 driver lines are available to express FLP selectively in a tissue or cell type of choice. For example, hundreds of fly lines have been established that express FLP in specific subsets of brain cells (38). Unlike cell type specific chromatin immunoprecipitation methods (39,40) the STOP#1-Dam strategy does not require purification of the cell type of interest. We illustrated this here for glial cells, which constitute only ∼10% of the fly brain.
Earlier reports also described FLP-inducible (41) and Cre-inducible (42) DamID systems employing respectively the terminator cassettes STOP#4 and STOP#3, but their utility for cell type specific DamID was not tested. Considering that STOP#3 and STOP#4 are relatively leaky in our hands, these termination cassettes may not be suited for this purpose. Southall and colleagues developed another system for inducible expression of Dam fusion proteins (14). Here, the expression vector consists of a GAL4-inducible promoter followed by open reading frame that encodes green fluorescent protein (GFP), and a second open reading frame that encodes the Dam fusion protein; expression of the latter is very low because it relies on inefficient ribosome reinitiation. As a proof-of-principle for this method, lineage-specific binding maps of RNA polymerase II in fly brain were produced (14). An additional opportunity for control of DamID activity is the use of a split-protein complementation version of DamID that was recently reported for mammalian cells (43). How these systems and ours compare in terms of cell type specificity of the DamID data (which is mostly determined by the degree of leaky expression in the non-target cells) may be tested in the future. Possibly these strategies may be combined to further reduce cross-talk from non-target cell types. Regardless, our data provide new evidence for the feasibility of cell type specific DamID mapping in small tissue samples. Our new vectors expand the suite of available tools for cell type specific studies of chromatin in complex tissues, which is a largely unexplored area of biology.
AVAILABILITY
Vectors for transgenesis with Dam4-HT-intein@L127C and STOP#1-Dam proteins are available through Addgene (accession numbers 71805–71812). Fly lines and other plasmids are available upon request.
Supplementary Material
Acknowledgments
We thank T. Sixma for help with the selection of positions within Dam to insert the intein; V.V. Shloma, J. van Bemmel and G. Filion for help with experiments and data analyses; S. de Vries and the NKI Genomics Core Facility for technical support; J. Kind and M. Amendola for helpful suggestions; B. Tolhuis and J. van Bemmel for sharing unpublished results; D. Liu, G. Struhl, E. Marois, C. Klämbt and F. Karch for flies and plasmids.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
EURYI, NWO/ALW-VICI, the Netherlands Consortium for Systems Biology and ERC Advanced Grant 293662—CHROMATINPRINCIPLES to B.v.S.; Russian fundamental scientific research project 0310-2014-0002 to A.V.P. Funding for open access charge: ERC Advanced Grant [293662].
Conflict of interest statement. None declared.
REFERENCES
- 1.van Steensel B., Henikoff S. Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase. Nat. Biotechnol. 2000;18:424–428. doi: 10.1038/74487. [DOI] [PubMed] [Google Scholar]
- 2.van Steensel B., Delrow J., Henikoff S. Chromatin profiling using targeted DNA adenine methyltransferase. Nat. Genet. 2001;27:304–308. doi: 10.1038/85871. [DOI] [PubMed] [Google Scholar]
- 3.Guelen L., Pagie L., Brasset E., Meuleman W., Faza M.B., Talhout W., Eussen B.H., de Klein A., Wessels L., de Laat W., et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature. 2008;453:948–951. doi: 10.1038/nature06947. [DOI] [PubMed] [Google Scholar]
- 4.Germann S., Juul-Jensen T., Letarnec B., Gaudin V. DamID, a new tool for studying plant chromatin profiling in vivo, and its use to identify putative LHP1 target loci. Plant J. 2006;48:153–163. doi: 10.1111/j.1365-313X.2006.02859.x. [DOI] [PubMed] [Google Scholar]
- 5.Venkatasubrahmanyam S., Hwang W.W., Meneghini M.D., Tong A.H., Madhani H.D. Genome-wide, as opposed to local, antisilencing is mediated redundantly by the euchromatic factors Set1 and H2AZ. Proc. Natl. Acad. Sci. U.S.A. 2007;104:16609–16614. doi: 10.1073/pnas.0700914104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Woolcock K.J., Gaidatzis D., Punga T., Buhler M. Dicer associates with chromatin to repress genome activity in Schizosaccharomyces pombe. Nat. Struct. Mol. Biol. 2011;18:94–99. doi: 10.1038/nsmb.1935. [DOI] [PubMed] [Google Scholar]
- 7.Towbin B.D., Gonzalez-Aguilera C., Sack R., Gaidatzis D., Kalck V., Meister P., Askjaer P., Gasser S.M. Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell. 2012;150:934–947. doi: 10.1016/j.cell.2012.06.051. [DOI] [PubMed] [Google Scholar]
- 8.Gonzalez-Aguilera C., Ikegami K., Ayuso C., de Luis A., Iniguez M., Cabello J., Lieb J.D., Askjaer P. Genome-wide analysis links emerin to neuromuscular junction activity in Caenorhabditis elegans. Genome Biol. 2014;15:R21. doi: 10.1186/gb-2014-15-2-r21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Schuster E., McElwee J.J., Tullet J.M., Doonan R., Matthijssens F., Reece-Hoyes J.S., Hope I.A., Vanfleteren J.R., Thornton J.M., Gems D. DamID in C. elegans reveals longevity-associated targets of DAF-16/FoxO. Mol. Syst. Biol. 2010;6:399. doi: 10.1038/msb.2010.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Filion G.J., van Bemmel J.G., Braunschweig U., Talhout W., Kind J., Ward L.D., Brugman W., de Castro I.J., Kerkhoven R.M., Bussemaker H.J., et al. Systematic protein location mapping reveals five principal chromatin types in Drosophila cells. Cell. 2010;143:212–224. doi: 10.1016/j.cell.2010.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.van Bemmel J.G., Filion G.J., Rosado A., Talhout W., de Haas M., van Welsem T., van Leeuwen F., van Steensel B. A network model of the molecular organization of chromatin in Drosophila. Mol. Cell. 2013;49:759–771. doi: 10.1016/j.molcel.2013.01.040. [DOI] [PubMed] [Google Scholar]
- 12.Greil F., Moorman C., van Steensel B. DamID: mapping of in vivo protein-genome interactions using tethered DNA adenine methyltransferase. Methods Enzymol. 2006;410:342–359. doi: 10.1016/S0076-6879(06)10016-6. [DOI] [PubMed] [Google Scholar]
- 13.Vogel M.J., Pagie L., Talhout W., Nieuwland M., Kerkhoven R.M., van Steensel B. High-resolution mapping of heterochromatin redistribution in a Drosophila position-effect variegation model. Epigenet. Chromatin. 2009;2:1. doi: 10.1186/1756-8935-2-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Southall T.D., Gold K.S., Egger B., Davidson C.M., Caygill E.E., Marshall O.J., Brand A.H. Cell-type-specific profiling of gene expression and chromatin binding without cell isolation: assaying RNA Pol II occupancy in neural stem cells. Dev. Cell. 2013;26:101–112. doi: 10.1016/j.devcel.2013.05.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kind J., Pagie L., de Vries S.S., Nahidiazar L., Dey S.S., Bienko M., Zhan Y., Lajoie B., de Graaf C.A., Amendola M., et al. Genome-wide Maps of Nuclear Lamina Interactions in Single Human Cells. Cell. 2015;163:134–147. doi: 10.1016/j.cell.2015.08.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wines D.R., Talbert P.B., Clark D.V., Henikoff S. Introduction of a DNA methyltransferase into Drosophila to probe chromatin structure in vivo. Chromosoma. 1996;104:332–340. doi: 10.1007/BF00337221. [DOI] [PubMed] [Google Scholar]
- 17.Choksi S.P., Southall T.D., Bossing T., Edoff K., de Wit E., Fischer B.E., van Steensel B., Micklem G., Brand A.H. Prospero acts as a binary switch between self-renewal and differentiation in Drosophila neural stem cells. Dev. Cell. 2006;11:775–789. doi: 10.1016/j.devcel.2006.09.015. [DOI] [PubMed] [Google Scholar]
- 18.Bischof J., Maeda R.K., Hediger M., Karch F., Basler K. An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc. Natl. Acad. Sci. U.S.A. 2007;104:3312–3317. doi: 10.1073/pnas.0611511104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Silies M., Yuva Y., Engelen D., Aho A., Stork T., Klämbt C. Glial cell migration in the eye disc. J. Neurosci. 2007;27:13130–13139. doi: 10.1523/JNEUROSCI.3583-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106. doi: 10.1186/gb-2010-11-10-r106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Anders S., McCarthy D.J., Chen Y., Okoniewski M., Smyth G.K., Huber W., Robinson M.D. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protoc. 2013;8:1765–1786. doi: 10.1038/nprot.2013.099. [DOI] [PubMed] [Google Scholar]
- 22.Vogel M.J., Peric-Hupkes D., van Steensel B. Detection of in vivo protein-DNA interactions using DamID in mammalian cells. Nat. Protoc. 2007;2:1467–1478. doi: 10.1038/nprot.2007.148. [DOI] [PubMed] [Google Scholar]
- 23.Buskirk A.R., Ong Y.C., Gartner Z.J., Liu D.R. Directed evolution of ligand dependence: small-molecule-activated protein splicing. Proc. Natl. Acad. Sci. U.S.A. 2004;101:10505–10510. doi: 10.1073/pnas.0402762101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Skretas G., Wood D.W. Regulation of protein activity with small-molecule-controlled inteins. Protein Sci. 2005;14:523–532. doi: 10.1110/ps.04996905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Noren C.J., Wang J., Perler F.B. Dissecting the chemistry of protein splicing and its applications. Angew. Chem. Int. Ed. Engl. 2000;39:450–466. [PubMed] [Google Scholar]
- 26.Tolhuis B., Blom M., Kerkhoven R.M., Pagie L., Teunissen H., Nieuwland M., Simonis M., de Laat W., van Lohuizen M., van Steensel B. Interactions among Polycomb domains are guided by chromosome architecture. PLoS Genet. 2011;7:e1001343. doi: 10.1371/journal.pgen.1001343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Theodosiou N.A., Xu T. Use of FLP/FRT system to study Drosophila development. Methods. 1998;14:355–365. doi: 10.1006/meth.1998.0591. [DOI] [PubMed] [Google Scholar]
- 28.Kao C.F., Lee T. The Making and Un-making of Neuronal Circuits in Drosophila. 2012. In vivo single cell labeling techniques. doi:10.1007/978-1-61779-830-6_4. [Google Scholar]
- 29.Pickersgill H., Kalverda B., de Wit E., Talhout W., Fornerod M., van Steensel B. Characterization of the Drosophila melanogaster genome at the nuclear lamina. Nat. Genet. 2006;38:1005–1014. doi: 10.1038/ng1852. [DOI] [PubMed] [Google Scholar]
- 30.van Bemmel J.G., Pagie L., Braunschweig U., Brugman W., Meuleman W., Kerkhoven R.M., van Steensel B. The insulator protein SU(HW) fine-tunes nuclear lamina interactions of the Drosophila genome. PLoS One. 2010;5:e15013. doi: 10.1371/journal.pone.0015013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Peric-Hupkes D., Meuleman W., Pagie L., Bruggeman S.W., Solovei I., Brugman W., Graf S., Flicek P., Kerkhoven R.M., van Lohuizen M., et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol. Cell. 2010;38:603–613. doi: 10.1016/j.molcel.2010.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Golic M.M., Rong Y.S., Petersen R.B., Lindquist S.L., Golic K.G. FLP-mediated DNA mobilization to specific target sites in Drosophila chromosomes. Nucleic Acids Res. 1997;25:3665–3671. doi: 10.1093/nar/25.18.3665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Golic K.G., Lindquist S. The FLP recombinase of yeast catalyzes site-specific recombination in the Drosophila genome. Cell. 1989;59:499–509. doi: 10.1016/0092-8674(89)90033-0. [DOI] [PubMed] [Google Scholar]
- 34.Golic K.G., Golic M.M. Engineering the Drosophila genome: chromosome rearrangements by design. Genetics. 1996;144:1693–1711. doi: 10.1093/genetics/144.4.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Stork T., Engelen D., Krudewig A., Silies M., Bainton R.J., Klämbt C. Organization and function of the blood-brain barrier in Drosophila. J. Neurosci. 2008;28:587–597. doi: 10.1523/JNEUROSCI.4367-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jones B.W. Transcriptional control of glial cell development in Drosophila. Dev. Biol. 2005;278:265–273. doi: 10.1016/j.ydbio.2004.11.022. [DOI] [PubMed] [Google Scholar]
- 37.Peck S.H., Chen I., Liu D.R. Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells. Chem. Biol. 2011;18:619–630. doi: 10.1016/j.chembiol.2011.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bohm R.A., Welch W.P., Goodnight L.K., Cox L.W., Henry L.G., Gunter T.C., Bao H., Zhang B. A genetic mosaic approach for neural circuit mapping in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 2010;107:16378–16383. doi: 10.1073/pnas.1004669107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Deal R.B., Henikoff S. A simple method for gene expression and chromatin profiling of individual cell types within a tissue. Dev. Cell. 2010;18:1030–1040. doi: 10.1016/j.devcel.2010.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Bonn S., Zinzen R.P., Girardot C., Gustafson E.H., Perez-Gonzalez A., Delhomme N., Ghavi-Helm Y., Wilczynski B., Riddell A., Furlong E.E. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat. Genet. 2012;44:148–156. doi: 10.1038/ng.1064. [DOI] [PubMed] [Google Scholar]
- 41.Luo S.D., Shi G.W., Baker B.S. Direct targets of the D. melanogaster DSXF protein and the evolution of sexual development. Development. 2011;138:2761–2771. doi: 10.1242/dev.065227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Maksimov D.A., Koryakov D.E., Belyakin S.N. Developmental variation of the SUUR protein binding correlates with gene regulation and specific chromatin types in D. melanogaster. Chromosoma. 2014;123:253–264. doi: 10.1007/s00412-013-0445-6. [DOI] [PubMed] [Google Scholar]
- 43.Hass M.R., Liow H.H., Chen X., Sharma A., Inoue Y.U., Inoue T., Reeb A., Martens A., Fulbright M., Raju S., et al. SpDamID: marking DNA bound by protein complexes identifies notch-dimer responsive enhancers. Mol. Cell. 2015;59:685–697. doi: 10.1016/j.molcel.2015.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Struhl G., Fitzgerald K., Greenwald I. Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo. Cell. 1993;74:331–345. doi: 10.1016/0092-8674(93)90424-o. [DOI] [PubMed] [Google Scholar]
- 45.Struhl G., Basler K. Organizing activity of wingless protein in Drosophila. Cell. 1993;72:527–540. doi: 10.1016/0092-8674(93)90072-x. [DOI] [PubMed] [Google Scholar]
- 46.Chintapalli V.R., Wang J., Dow J.A. Using FlyAtlas to identify better Drosophila melanogaster models of human disease. Nat. Genet. 2007;39:715–720. doi: 10.1038/ng2049. [DOI] [PubMed] [Google Scholar]
- 47.Lakso M., Sauer B., Mosinger B., Jr, Lee E.J., Manning R.W., Yu S.H., Mulder K.L., Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 1992;89:6232–6236. doi: 10.1073/pnas.89.14.6232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Stockinger P., Kvitsiani D., Rotkopf S., Tirian L., Dickson B.J. Neural circuitry that governs Drosophila male courtship behavior. Cell. 2005;121:795–807. doi: 10.1016/j.cell.2005.04.026. [DOI] [PubMed] [Google Scholar]
- 49.Marois E., Eaton S. RNAi in the Hedgehog signaling pathway: pFRiPE, a vector for temporally and spatially controlled RNAi in Drosophila. Methods Mol. Biol. 2007;397:115–128. doi: 10.1007/978-1-59745-516-9_10. [DOI] [PubMed] [Google Scholar]
- 50.Horton J.R., Liebert K., Bekes M., Jeltsch A., Cheng X. Structure and substrate recognition of the Escherichia coli DNA adenine methyltransferase. J. Mol. Biol. 2006;358:559–570. doi: 10.1016/j.jmb.2006.02.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.